Staff Profile
Dr Rajesh Nair
Honorary Fellow and associate clinical researcher, Consultant psychiatrist
- Email: rajesh.nair@ncl.ac.uk
- Address: Adult ADHD service
Keegan Court
Grassbanks health centre
Gateshead
NE10 8DX
Consultant psychiatrist for Adult neurodevelopemental disorders
UKAAN Lead for the North East of England
Member of CADDRA research committee
Sub I PAX-BD - pramiprexole in depression study.
PI for digital medicines trial
PI for Ketamine in ECT trial
PI for LQD trial (TEWV)
Sub I Intranasal ketamine study
New projects to be commenced
CI for UK Landscape study
PI for SNAPPER Study
Co investigator for multimodal sensing in ADHD (funding submitted)
Honorary Fellow Newcastle University
Educational supervisor for FY1 trainees
Clinical supervisor for Core trainees
Clinical supervisor for CESR fellow
Clinical supervisor for Overseas Fellowship scheme
Clinical supervisor for Physician associate students
Clinical supervisor for Nurse medical prescribers
Clinical examiner for CASC exam conducted by Royal college of psychiatrists
Educational supervision for third and fifth year medical students
- Trevithick L, McAllister-Williams RH, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Ellwell C, Hayden K, Holland F, Karim S, Lowe J, Loo C, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, Anderson IM. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study). BMC Psychiatry 2015, 15, 257.
- Nair R, Reading R, Killilea k. Great Imitator. Journal of Neurology, Neurosurgery and Psychiatry 2015, 86, e3.
- Bhogal K, Baldwin DS, Hartland L, Nair R. Differences between ethnic groups in demographic and clinical features of patients admitted and assessed after deliberate self-harm. International Journal of Social Psychiatry 2006, 52(6), 483-486.
- Baldwin S, Nair R. Escitalopram in the treatment of generalized anxiety disorder. Expert Opinion in Neurotherapeutics 2005, 5(4), 443-449.
- Anderson IM, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Elwell C, Hayden K, Holland F, Karim S, Loo C, Lowe J, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, McAllister-Williams RH. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): A multicentre, double-blind, randomised, parallel-group, superiority trial. The Lancet Psychiatry 2017, 4(5), 365-377.
- Gupta S, Lakshmanan D, Khastgir u, Nair R. Management of antipsychotic-induced hyperprolactinaemia. BJPsych Advances 2017, 23(4), 278-286.
- Marwood l, Taylor R, Goldsmith K, Romeo R, Holland R, Pickles A, Hutchinson J, Dietch D, Cipriani A, Nair R, Attenburrow MJ, Young AH, Geddes J, McAllister-Williams RH, Cleare AJ. Study Protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of Lithium and quetiapine augmentation in treatment resistant depression (the LQD study). BMC Psychiatry 2017, 17, 231.
- Palmos AB, Watson S, Hughes T, Finkelmeyer A, McAllister-Williams RH, Ferrier N, Anderson IM, Nair R, Young AH, Strawbridge R, Cleare AJ, Chung R, Frissa S, Goodwin L, Hotopf M, Hatch SL, Wang H, Collier DA, Thuret S, Breen G, Powell TR. Associations between childhood maltreatment and inflammatory markers. BJ Psych Open 2019, 5(1), e3.